Table 2.
Parameter estimates of population pharmacokinetic models.
| Drug | CL (l h−1) | Vd (l) | ωCL | ωVd | σ |
|---|---|---|---|---|---|
| Doxorubicin | 54.0 | 9.3 | 0.0296 | 0.0369 | 0.0140 |
| s.d.: 4.96 | s.d.:0.970 | s.d.:0.0012 | s.d.:0.0020 | 0.0015 s.d.:0.0085 | |
| Etoposide | 3.34–0.0083*SCr | 6.4 | 0.0243 | 0.0350 | 0.0576 |
| s.d.:0.228 | s.d.:0.863 | s.d.:0.0107 | s.d.:0.0128 | s.d.:0.0213 | |
| Ifosfamide | Day 1 : 5.6 | 26.0 | 0.0100 | 0.0296 | 0.0042 |
| s.d.:0.330 | s.d.:0 4.49 | s.d.:0.0044 | s.d.:0.0084 | 0.2100 | |
| Day 2 : 7.95 | s.d.:0.0043 | ||||
| s.d.:0.450 |
CL: Clearance. Vd: Volume of distribution. SCr: Serum creatinine (µmol l−1).